Sitagliptin vs Fluoxetine: side-by-side comparison
Sitagliptin (DPP-4 inhibitor) and Fluoxetine (Selective serotonin reuptake inhibitor (SSRI)) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Sitagliptin | Fluoxetine |
|---|---|---|
| Therapeutic class | DPP-4 inhibitor | Selective serotonin reuptake inhibitor (SSRI) |
| CAS | 486460-32-6 | 54910-89-3 |
| ATC | A10BH01 | N06AB03 |
| Molecular weight | 407.31 g/mol | 309.33 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Sitagliptin and Fluoxetine share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Sitagliptin acts by a different mechanism than Fluoxetine, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Sitagliptin: La sitagliptine inhibe de façon réversible la DPP-4, sérine protéase responsable de la dégradation rapide du glucagon-like peptide 1 (GLP-1) et du polypeptide insulinotrope glucose-dépendant (GIP). Fluoxetine: La fluoxétine inhibe sélectivement le transporteur de recapture de la sérotonine, augmentant la disponibilité synaptique de la sérotonine.
Indications compared
Sitagliptin: La sitagliptine est autorisée chez l'adulte atteint de diabète de type 2, seule ou en association à d'autres antidiabétiques, pour améliorer le contrôle glycémique. Fluoxetine: La fluoxétine est autorisée dans la dépression caractérisée (adulte et enfant à partir de 8 ans), le trouble obsessionnel compulsif, la boulimie nerveuse, le trouble panique et le trouble dysphorique prémenstruel.
Safety profile
Sitagliptin: La sitagliptine est généralement bien tolérée. Fluoxetine: Les effets indésirables fréquents comprennent nausées, céphalées, troubles du sommeil, troubles de la fonction sexuelle et diminution de l'appétit.
Questions fréquentes
Is Sitagliptin better than Fluoxetine? ▾
Sitagliptin and Fluoxetine are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Sitagliptin and Fluoxetine be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Sitagliptin
Products with Fluoxetine
Les informations publiées sur ce site sont fournies à titre documentaire et pédagogique. Elles ne remplacent pas l'avis d'un professionnel de santé qualifié.